Skip to main content
Clinical Trials/NCT02529982
NCT02529982CompletedNot Applicable

The Effect of Curcumin Supplementation on Anthropometric Indices, Insulin Resistance and Oxidative Stress in Patients With Type 2 Diabetes

National Nutrition and Food Technology Institute2 sites in 1 country44 target enrollmentStarted: July 1, 2015Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
44
Locations
2
Primary Endpoint
Insulin

Study Overview

Brief Summary

Diabetes mellitus is the most common endocrine disorder, causes many complications such as micro- and macro-vascular diseases. Various kinds of antidiabetic drugs have been developed, but most of them have side effects. Recently, the use of natural plant products has gained more attention among scientists in order to prevent diabetic vascular complications. Curcumin is a natural yellow product derived from the turmeric rhizome which has shown to be non-toxic and exhibits various bio¬logical activities such as anti-oxidant, anti-inflammatory, anti-carcinogenic, and anti-diabetic effects. Curcumin is effective in reducing glycemic index and hyperlipidemia in rodent models and is relatively inexpensive and safe. Most of the studies conducted on animal model, and just a few of them are on human model. The present study was planned to evaluate the effects of curcumin supplementation The effect of curcumin supplementation on anthropometric indices, insulin resistance and oxidative stress in patients with type 2 diabetes

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Participant, Investigator)

Eligibility Criteria

Ages
40 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • insulin Inclusion Criteria:
  • a) Tendency to participate b) Age range of 40-65 c) Suffering from diabetes type 2 ( between 1 to 10 yeares) d) BMI 18/5-30 e) Patients with diabetes who administer oral hypoglycemic agents and do not use

Exclusion Criteria

  • a) patients with liver diseases b) patients with kidney diseases c) patients with inflammatory diseases d) patients with liver diseases e) Administering herbal agents f) Administering multivitamins and minerals in past 3 months

Arms & Interventions

control

Placebo Comparator

placebo

Intervention: Placebo (Dietary Supplement)

intervention

Active Comparator

500 mg curcumin capsule

Intervention: Curcumin (Dietary Supplement)

Outcomes

Primary Outcomes

Insulin

Time Frame: 10 week

HbA1c

Time Frame: 10 week

fasting blood sugar

Time Frame: 10 weeks

Homeostatic Model Assessment of Insulin Resistance

Time Frame: 10 week

Change in pancreatic B-cell function

Time Frame: 10 week

Secondary Outcomes

  • total capacity antioxidant(10 weeks)
  • Malondialdehyde(10 week)
  • Body mass index(10 week)
  • Waist circumference(10 week)

Investigators

Sponsor
National Nutrition and Food Technology Institute
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Dr Azita Hekmatdoost

Principal Investigator

National Nutrition and Food Technology Institute

Study Sites (2)

Loading locations...

Similar Trials